Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Virpax Pharmaceuticals, Inc. (VRPX)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Net income | -3.1 | -1.5 | -3.0 | -7.6 | -5.9 | -5.1 | -4.1 | -3.2 |
| Stock-based compensation | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| Change in working capital [+] | 0.7 | -0.6 | 1.3 | 2.0 | 0.9 | -1.1 | -0.9 | -1.5 |
| Other current assets | 0.4 | -0.8 | 2.4 | 0.3 | 0.6 | -1.2 | -1.7 | -0.1 |
| Other | 0.4 | 0.2 | -1.1 | 1.7 | 0.3 | 0.1 | 0.8 | -1.4 |
| Other operating activities | | | | | | | | -0.1 |
| Cash from operations | -2.2 | -2.0 | -1.6 | -5.5 | -4.7 | -6.0 | -4.9 | -4.7 |
| |
| Capital expenditures | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash from investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Issuance of common stock, net | | | | | | | | 40.0 |
| Financing costs | | | | | | | 0.1 | |
| Other cash from financing | | | | | | | 0.1 | -4.0 |
| Cash from financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 36.0 |
| |
| Free cash flow | -2.2 | -2.0 | -1.6 | -5.5 | -4.7 | -6.0 | -4.9 | -4.7 |
| Per share (diluted) | ($0.19) | ($0.17) | ($0.13) | ($0.47) | ($0.40) | ($0.52) | ($0.74) | ($0.79) |
| |
| Cash paid for interest | | | | | | | 0.0 | 0.3 |
|